For single cancer cell surface protein expressions such as human epidermal growth factor receptor 2 (HER2) or single cancer gene mutations such as BCR-ABL fusion, there are clear diagnostics and therapeutic guidelines for care [1, 2]. This evidence concerns the gene BCR and cancer.